INSIDERFilingvia Quantisnow
CryoPort Inc. logo

CryoPort (CYRX) CEO Shelton acquired 25,000 shares at $5.00

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Jerrell Shelton (President, CEO at CryoPort Inc., CYRX) reported that they acquired 25,000 shares at $5.00 on Jul 24, 2025. After these transactions the filing shows 1,012,419 shares held directly.

Reporting person
Shelton Jerrell
Role
President, CEO
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jul 24, 2025Exercise or conversion of a derivative (M)Common Stock1+25,000$5.00$125K1,012,419 direct

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jul 24, 2025Exercise or conversion of a derivative (M)Stock Option (right to buy)On 25,000 Common Stock1, 2-25,000--50,000 direct

Holdings before and after

  • Common Stock: 987,419 to 1,012,419 direct
  • Stock Option (right to buy): 75,000 to 50,000 direct

Footnotes from the filing

  1. 1. This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock.
  2. 2. 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015.

Transaction codes in this filing

Exercise or conversion of a derivative:
Code M marks the exercise or conversion of an option or other derivative under an exempt plan.

FAQ

What did Shelton report in this CYRX Form 4?

Jerrell Shelton (President, CEO at CryoPort Inc., CYRX) reported that they acquired 25,000 shares at $5.00 on Jul 24, 2025. After these transactions the filing shows 1,012,419 shares held directly.

How many CYRX shares does Shelton hold after this filing?

The filing shows 1,012,419 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code M mean on an SEC Form 4?

Code M marks the exercise or conversion of an option or other derivative under an exempt plan.

Historical context for CYRX

Earlier insider filings at CYRX

Quantisnow market dataNASDAQ
CryoPort Inc. logo
CYRX
CryoPort Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for CYRX

Follow CYRX and get a push notification the moment its next story breaks.

Full CYRX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CYRX (CryoPort Inc.) and more on Quantisnow.